C3 Activation Products, C3 Containing Immune Complexes, the Terminal Complement Complex and Native C9 in Patients with Rheumatoid Arthritis-Reference-Cited by-同舟云学术

C3 Activation Products, C3 Containing Immune Complexes, the Terminal Complement Complex and Native C9 in Patients with Rheumatoid Arthritis

Published:1991-01 Issue:3 Volume:20 Page:183-189
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Ölmez Ü.,Garred P.,Mollnes T. E.,Harboe M.,Berntzen H. B.,Munthe E.

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

http://www.tandfonline.com/doi/pdf/10.3109/03009749109103019

Reference25 articles.

1. Ruddy S. Plasma protein effectors of inflammation: complement, Textbook of Rheumatology.Second Edition., WN Kelley, Jr, ED Harris, S Ruddy, CB Sledge. WB Saunders, Philadelphia 1985; 83–94

2. Activation-Dependent Epitopes in the Terminal Complement Pathway

3. Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex

4. Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C3 Gene Functional Polymorphisms and C3 Serum Levels in Patients with Rheumatoid Arthritis;Immunological Investigations;2020-08-12

2. Effector Mechanisms in Autoimmunity;The Autoimmune Diseases;2020

3. A review of human diseases caused or exacerbated by aberrant complement activation;Neurobiology of Aging;2017-04

4. CD55 deposited on synovial collagen fibers protects from immune complex-mediated arthritis;Arthritis Research & Therapy;2015

5. Effector Mechanisms in Autoimmunity;The Autoimmune Diseases;2014